Prevalence and Clinical Implications of a β-Amyloid–Negative, Tau-Positive Cerebrospinal Fluid Biomarker Profile in Alzheimer Disease
Pontus Erickson(University of Gothenburg), Prashanthi Vemuri(Mayo Clinic in Arizona), Tobey J. Betthauser(University of Wisconsin–Madison), Joel Simrén(University of Gothenburg), Enchi Liu(University of Washington), Arthur W. Toga(University of California, Los Angeles), Danielle Harvey(UC San Diego Health System), Nick C. Fox(NIHR Queen Square Dementia Biomedical Research Unit), Gus Jiminez(UC San Diego Health System), Barbara B. Bendlin(University of Wisconsin–Madison), John Q. Trojanowki(University of Southern California), Kaj Blennow(Sahlgrenska University Hospital), Andrew J. Saykin(Alzheimer’s Disease Neuroimaging Initiative), Tamie Sather(University of California San Diego), Wagner S. Brum(Universidade Federal do Rio Grande do Sul), Michael Donohue(Alzheimer’s Disease Neuroimaging Initiative), Tom Montine(University of Washington), Erin M. Jonaitis(University of Wisconsin–Madison), Paul Aisen(University of California, San Diego), Ronald G. Thomas(UC San Diego Health System), Carol A. Van Hulle(University of Wisconsin–Madison), Norbert Schuff(University of California, Davis), Ronald C. Petersen(Mayo Clinic in Arizona), Sarah Walter(UC San Diego Health System), Matthew L. Senjem(Mayo Clinic in Florida), Bret Borowski(Mayo Clinic in Florida), Ulf Andréasson(Sahlgrenska University Hospital), Laurel Beckett(Brigham and Women's Hospital), William J. Jagust(Lawrence Berkeley National Laboratory), John C. Morris(Washington University in St. Louis), Ivonne Suridjan(AbbVie (United States)), Gwendlyn Kollmorgen(Roche Pharma AG (Germany)), Sterling C. Johnson(Wisconsin Society for Cardiovascular and Pulmonary Health & Rehabilitation), Matt A. Bernstein(University of London), Cynthia M. Carlsson(University of Wisconsin–Madison), Gilda E. Ennis(University of Wisconsin–Madison), Paul M. Thompson(University of Southern California), Leslie M. Shaw(California University of Pennsylvania), Robert C. Green(Boston University), Michael W. Weiner(University of California, San Francisco), Sanjay Asthana(University of Wisconsin–Madison), Devon Gessert(UC San Diego Health System), Rebecca Langhough(University of Wisconsin–Madison), Henrik Zetterberg(University of Wisconsin System), Clifford R. Jack(Mayo Clinic), Jeff Gunter(Mayo Clinic in Florida), Nicholas J. Ashton(King's College London)
Cited by 46
Related Papers
The diagnosis of dementia due to Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|18.9k
NIA‐AA Research Framework: Toward a biological definition of Alzheimer's disease
|Alzheimer s & Dementia|2018|10.4k
Mild cognitive impairment as a diagnostic entity
|Journal of Internal Medicine|2004|7.8k
Toward defining the preclinical stages of Alzheimer's disease: Recommendations from the National Institute on Aging‐Alzheimer's Association workgroups on diagnostic guidelines for Alzheimer's disease
|Alzheimer s & Dementia|2011|7.1k
Neuroimaging standards for research into small vessel disease and its contribution to ageing and neurodegeneration
|The Lancet Neurology|2013|5.4k